Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. announced an updated set of rules governing the convening and conduct of shareholders’ meetings, effective from 26 November 2025. The document outlines clear procedures on proposal submission, notice periods, meeting organization, and voting methods.
The announcement specifies that shareholders who individually or jointly hold over 1% of the Company’s shares can submit written proposals up to ten days before a meeting. For annual general meetings, a 20-day notice period is required, while extraordinary general meetings call for a 15-day notice. The procedures also clarify that resolutions can be passed by ordinary or special rulings, with special resolutions requiring the approval of at least two-thirds of voting rights present.
Voting mechanisms feature both onsite and online channels; each shareholder is entitled to one vote per share unless the cumulative voting system is used. When reviewing connected transactions, shareholders with related interests must abstain. The announcement additionally details special procedures for class shareholders and requires legal counsel to verify compliance with the prescribed processes.
The updated rules affirm that the board of directors bears responsibility for implementing shareholders’ meeting decisions and that meeting minutes, attendance registers, and proxies must be retained for at least ten years. The announcement underscores the importance of adhering to these procedures to maintain effective corporate governance and protect shareholders’ rights.
Comments